Biotech Values

[mcbio]

There will also be a $50 million milestone due to PGNX when the oral Relistor formulation is approved, and it should be submitted for approval in a few months.

But it's hard to imagine the issues with the subQ won't carry over to the oral formulation. So, it's really hard to say about timing of any approval as additional trials could be required for both subQ and oral.